Cancer management during the COVID-19 world pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer management during the COVID-19 world pandemic

Published:2023-08-29 Issue:11 Volume:72 Page:3427-3444
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Sobhani Navid,Mondani Giuseppina,Roviello Giandomenico,Catalano Martina,Sirico Marianna,D’Angelo Alberto,Scaggiante Bruna,Generali Daniele

Funder

MEDnoTE srl

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-023-03524-1.pdf

Reference129 articles.

1. Seneviratne SL, Wijerathne W, Yasawardene P, Somawardana B (2022) COVID-19 in cancer patients. Trans R Soc Trop Med Hyg. https://doi.org/10.1093/trstmh/trac015

2. Kamboj M, Sepkowitz KA (2009) Nosocomial infections in patients with cancer. Lancet Oncol 10:589–597. https://doi.org/10.1016/S1470-2045(09)70069-5

3. Li J-Y, Duan X-F, Wang L-P, Xu Y-J, Huang L, Zhang T-F et al (2014) Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer. J Immunol Res. https://doi.org/10.1155/2014/286170

4. Longbottom ER, Torrance HDT, Owen HC, Fragkou PC, Hinds CJ, Pearse RM et al (2016) Features of postoperative immune suppression are reversible with interferon gamma and independent of interleukin-6 pathways. Ann Surg 264:370–377. https://doi.org/10.1097/SLA.0000000000001484

5. Sica A, Massarotti M (2017) Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun 85:117–125. https://doi.org/10.1016/j.jaut.2017.07.010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of the COVID-19 Pandemic on Melanoma Diagnosis: A Single-Center Study;Diagnostics;2024-09-13

2. Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection;Infectious Agents and Cancer;2024-03-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3